Search
Search
Eyewire News: The Podcast
05.27.26
Outlook Therapeutics takes a major step forward in its plan to gain approval for wet AMD drug Lytenava; the first commercial FLIGHT procedures using the ViaLuxe Laser System are performed in Europe; and Oculus introduces a new AI-assisted tool designed to help clinicians evaluate MGD using meibography images. Learn more about your ad choices. Visit megaphone.fm/adchoices
View full description +
Subscribe
05.13.26
Future of Posterior TherapeuticsShow More
